Med. praxi. 2022;19(3):165-168 | DOI: 10.36290/med.2022.025
Current issues in pneumococcal infections
- Plicní oddělení, Medicon, a. s., Praha
Inflammatory bacterial diseases of the respiratory tract are among frequent and serious conditions in both paediatric and adult populations. Streptococcus pneumoniae is the most common causative agent that causes severe infectious diseases, ranging from otitis and pneumonia, sometimes complicated by empyema, to meningitis. If the bacterium reaches the bloodstream, it can cause invasive pneumococcal disease. Transmission occurs through droplet infection when coughing or sneezing. The course of the disease can be negatively affected by chronic, associated conditions and immunosenescence. The risk groups include children, the elderly, and immunosuppressed patients. Pneumococcal vaccination is an important preventive measure. The aim is to prevent pneumococcal infection or, in case it develops, to alleviate its course.
Keywords: Streptococcus pneumoniae, pneumococcal infections, invasive pneumococcal disease, pneumonia, pneumococcal vaccine, risk groups.
Published: June 16, 2022 Show citation
References
- Prymula R. Očkování proti pneumokokovým onemocněním. In: Chlíbek R, et al. Očkování dospělých. Praha: Mladá fronta; 2019. p. 150-160.
- Goncalves JM, Martín NB, Mendez LI, et al. Impact of 13-valent pneumococal conjugate polysaccharide vaccination in exacerbations rate of COPD patients with moderate to severe obstruction. Respir Med. 2018;137:6-13.
Go to PubMed... - Froes F, Diniz A, Mesquita M, et al. Hospital admissions of adults with community‑acquired pneumonia in Portugal between 2000 and 2009. Eur Respir J. 2013;41:1141-1146.
Go to original source... Go to PubMed... - Kolek V. Infekční pneumonie. In: Kolek V, Kašák V, et al. Pneumologie. Praha: Maxdorf Jessenius: 2014; p. 121-143.
- Thomas RE. Pneumococcal pneumonia and invasive pneumococcal disease in those 65 and older: Rates of detection, risk factors, vaccine effectiveness, hospitalisation and mortality. Geriatrics. 2021;6:1-20. Go to original source... Go to PubMed...
- Jakubec P, Kolek V, Kolář M. Diagnostika a léčba těžké pneumonie, Standard léčebného plánu 2019. Available from: http://www.pneumologie.cz.
- Kolek V. Pneumonie. In: Kolek V, et al. Doporučené postupy v pneumologii. Praha: Maxdorf; 2019. p. 107-140.
- Prevenar 13: Vakcína proti pneumokokovým infekcím. Available from: https://www.prevenar.cz/pneumokokova‑vakcina‑prevenar-13.
- Dušek L. Aktuální data Národního zdravotnického informačního systému. Available from: https.//www.vakcinace.eu/data//files/hradeckevakcinologickednyy2019/9.
- Torres A, Cillónz C, Blasi F, et al. Burden of pneumococcal community‑acquired pneumonia in adults across Europe: A literature review Respir Med. 2018;137:6-13. Go to original source... Go to PubMed...